|
1
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huang L, Wu RL and Xu AM:
Epithelial-mesenchymal transition in gastric cancer. Am J Transl
Res. 7:2141–2158. 2015.
|
|
4
|
Yan Y, Zhang J, Li JH, Liu X, Wang JZ, Qu
HY, Wang JS and Duan XY: High tumor-associated macrophages
infiltration is associated with poor prognosis and may contribute
to the phenomenon of epithelial-mesenchymal transition in gastric
cancer. Onco Targets Ther. 9:3975–3983. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peng Z, Wang CX, Fang EH, Wang GB and Tong
Q: Role of epithelial-mesenchymal transition in gastric cancer
initiation and progression. World J Gastroenterol. 20:5403–5410.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bedi U, Mishra VK, Wasilewski D, Scheel C
and Johnsen SA: Epigenetic plasticity: A central regulator of
epithelial-to-mesenchymal transition in cancer. Oncotarget.
5:2016–2029. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, et
al: Functional demarcation of active and silent chromatin domains
in human HOX loci by noncoding RNAs. Cell. 129:1311–1323. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marchese FP and Huarte M: Long non-coding
RNAs and chromatin modifiers: Their place in the epigenetic code.
Epigenetics. 9:21–26. 2014. View Article : Google Scholar :
|
|
9
|
Kogo R, Shimamura T, Mimori K, Kawahara K,
Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, et al:
Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin
modification and is associated with poor prognosis in colorectal
cancers. Cancer Res. 71:6320–6326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Amicone L, Citarella F and Cicchini C:
Epigenetic regulation in hepatocellular carcinoma requires long
noncoding RNAs. Biomed Res Int. 2015.1–10. 2015. View Article : Google Scholar
|
|
11
|
Hajjari M and Salavaty A: HOTAIR: An
oncogenic long non-coding RNA in different cancers. Cancer Biol
Med. 12:1–9. 2015.PubMed/NCBI
|
|
12
|
Zhou X, Ren Y, Zhang J, Zhang C, Zhang K,
Han L, Kong L, Wei J, Chen L, Yang J, et al: HOTAIR is a
therapeutic target in glioblastoma. Oncotarget. 6:8353–8365.
2015.PubMed/NCBI
|
|
13
|
Tsai MC, Manor O, Wan Y, Mosammaparast N,
Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as
modular scaffold of histone modification complexes. Science.
329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Baylin SB and Ohm JE: Epigenetic gene
silencing in cancer - a mechanism for early oncogenic pathway
addiction? Nat Rev Cancer. 6:107–116. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ning X, Shi Z, Liu X, Zhang A, Han L,
Jiang K, Kang C and Zhang Q: DNMT1 and EZH2 mediated methylation
silences the microRNA-200b/a/429 gene and promotes tumor
progression. Cancer Lett. 359:198–205. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu YW, Sun M, Xia R, Zhang EB, Liu XH,
Zhang ZH, Xu TP, De W, Liu BR and Wang ZX: LincHOTAIR
epigenetically silences miR34a by binding to PRC2 to promote the
epithelial-to-mesenchymal transition in human gastric cancer. Cell
Death Dis. 6:e1802–e1811. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Margueron R and Reinberg D: Chromatin
structure and the inheritance of epigenetic information. Nat Rev
Genet. 11:285–296. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pradeepa MM, Grimes GR, Kumar Y, Olley G,
Taylor GC, Schneider R and Bickmore WA: Histone H3 globular domain
acetylation identifies a new class of enhancers. Nat Genet.
48:681–686. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Greer EL and Shi Y: Histone methylation: A
dynamic mark in health, disease and inheritance. Nat Rev Genet.
13:343–357. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li KK, Luo C, Wang D, Jiang H and Zheng
YG: Chemical and biochemical approaches in the study of histone
methylation and demethylation. Med Res Rev. 32:815–867. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim YW and Kim A: Characterization of
histone H3K27 modifications in the β-globin locus. Biochem Biophys
Res Commun. 405:210–215. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu ZY, Yu QM, Du YA, Yang LT, Dong RZ,
Huang L, Yu PF and Cheng XD: Knockdown of long non-coding RNA
HOTAIR suppresses tumor invasion and reverses
epithelial-mesenchymal transition in gastric cancer. Int J Biol
Sci. 9:587–597. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hajjari M, Behmanesh M, Sadeghizadeh M and
Zeinoddini M: Up-regulation of HOTAIR long non-coding RNA in human
gastric adenocarcinoma tissues. Med Oncol. 30:670–673. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fang XY, Pan HF, Leng RX and Ye DQ: Long
noncoding RNAs: Novel insights into gastric cancer. Cancer Lett.
356:357–366. 2015. View Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) methods. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
26
|
Perl AK, Wilgenbus P and Dahl U: Acausal
role for E-cadherin in the transition from adenomato carcinoma.
Nature. 392:190–193. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pasini D, Malatesta M, Jung HR,
Walfridsson J, Willer A, Olsson L, Skotte J, Wutz A, Porse B,
Jensen ON, et al: Characterization of an antagonistic switch
between histone H3 lysine 27 methylation and acetylation in the
transcriptional regulation of Polycomb group target genes. Nucleic
Acids Res. 38:4958–4969. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Latham JA and Dent SY: Cross-regulation of
histone modifications. Nat Struct Mol Biol. 14:1017–1024. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Battistelli C, Cicchini C, Santangelo L,
Tramontano A, Grassi L, Gonzalez FJ, de Nonno V, Grassi G, Amicone
L and Tripodi M: The Snail repressor recruits EZH2 to specific
genomic sites through the enrollment of the lncRNA HOTAIR in
epithelial-to-mesenchymal transition. Oncogene. 10:1–14. 2016.
|
|
31
|
Liu L, Xu Z, Zhong L, Wang H, Jiang S,
Long Q, Xu J and Guo J: Enhancer of zeste homolog 2 (EZH2) promotes
tumour cell migration and invasion via epigenetic repression of
E-cadherin in renal cell carcinoma. BJU Int. 117:351–362. 2016.
View Article : Google Scholar
|
|
32
|
Wu Y, Zhang L, Zhang L, Wang Y, Li H, Ren
X, Wei F, Yu W, Liu T, Wang X, et al: Long non-coding RNA HOTAIR
promotes tumor cell invasion and metastasis by recruiting EZH2 and
repressing E-cadherin in oral squamous cell carcinoma. Int J Oncol.
46:2586–2594. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang JX, Han L, Bao ZS, Wang YY, Chen LY,
Yan W, Yu SZ, Pu PY, Liu N, You YP, et al Chinese Glioma
Cooperative Group: HOTAIR, a cell cycle-associated long noncoding
RNA and a strong predictor of survival, is preferentially expressed
in classical and mesenchymal glioma. Neuro Oncol. 15:1595–1603.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pan W, Liu L, Wei J, Ge Y, Zhang J, Chen
H, Zhou L, Yuan Q, Zhou C and Yang M: A functional lncRNA HOTAIR
genetic variant contributes to gastric cancer susceptibility. Mol
Carcinog. 55:90–96. 2016. View Article : Google Scholar
|
|
35
|
Zhao W, Dong S, Duan B, Chen P, Shi L, Gao
H and Qi H: HOTAIR is a predictive and prognostic biomarker for
patients with advanced gastric adenocarcinoma receiving
fluorouracil and platinum combination chemotherapy. Am J Transl
Res. 7:1295–1302. 2015.PubMed/NCBI
|
|
36
|
Chase A and Cross NC: Aberrations of EZH2
in cancer. Clin Cancer Res. 17:2613–2618. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tie F, Banerjee R, Stratton CA,
Prasad-Sinha J, Stepanik V, Zlobin A, Diaz MO, Scacheri PC and
Harte PJ: CBP-mediated acetylation of histone H3 lysine 27
antagonizes Drosophila Polycomb silencing. Development.
136:3131–3141. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Christiansen JJ and Rajasekaran AK:
Reassessing epithelial to mesenchymal transition as a prerequisite
for carcinoma invasion and metastasis. Cancer Res. 66:8319–8326.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zha L, Cao Q, Cui X, Li F, Liang H, Xue B
and Shi H: Epigenetic regulation of E-cadherin expression by the
histone demethylase UTX in colon cancer cells. Med Oncol. 33:21–31.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang Y and Shang Y: Epigenetic control of
epithelial-to-mesenchymal transition and cancer metastasis. Exp
Cell Res. 319:160–169. 2013. View Article : Google Scholar
|
|
42
|
Wang R, Chen X, Xu T, Xia R, Han L, Chen
W, De W and Shu Y: MiR-326 regulates cell proliferation and
migration in lung cancer by targeting phox2a and is regulated by
HOTAIR. Am J Cancer Res. 6:173–186. 2016.PubMed/NCBI
|
|
43
|
Wolff EM, Liang G and Jones PA: Mechanisms
of Disease: Genetic and epigenetic alterations that drive bladder
cancer. Nat Clin Pract Urol. 2:502–510. 2005. View Article : Google Scholar
|
